1. Prediction and monitoring of relapse in stage III melanoma using circulating tumor DNA. (6th February 2019) Authors: Tan, L; Sandhu, S; Lee, R J; Li, J; Callahan, J; Ftouni, S; Dhomen, N; Middlehurst, P; Wallace, A; Raleigh, J; Hatzimihalis, A; Henderson, M A; Shackleton, M; Haydon, A; Mar, V; Gyorki, D E; Oudit, D; Dawson, M A; Hicks, R J; Lorigan, P Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 804 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 52OCirculating tumour DNA analysis predicts relapse following resection in stage II and III melanoma. (23rd October 2018) Authors: Tan, L; Sandhu, S K; Lee, R; Li, J; Callahan, J; Raleigh, J; Hatzimihalis, A; Middlehurst, P; Henderson, M; Shackleton, M; Haydon, A; Gyorki, D; Oudit, D; Hicks, R J; Lorigan, P; McArthur, G A; Marais, R; Wong, S Q; Dawson, S-J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 341OClinical and FDG-PET markers of immune checkpoint inhibitor (ICI) response in patients with metastatic Merkel cell carcinoma (mMCC). (24th November 2019) Authors: Weppler, A M; Bhave, P; Ieso, P De; Chua, M; Raleigh, J; Hatzimihalis, A; Gill, A; Balachander, S; Callahan, J; Pattison, A; Caneborg, A; Yeung, G Au; McArthur, G; Hicks, R J; Tothill, R; Sandhu, S K Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗